|
VANGL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.592000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.762200E-01 |
| Normal-vs-Stage2 |
2.368800E-01 |
| Normal-vs-Stage3 |
4.123200E-01 |
| Normal-vs-Stage4 |
8.396000E-01 |
| Stage1-vs-Stage2 |
5.120600E-01 |
| Stage1-vs-Stage3 |
7.364800E-01 |
| Stage1-vs-Stage4 |
5.853400E-01 |
| Stage2-vs-Stage3 |
9.616200E-01 |
| Stage2-vs-Stage4 |
3.866800E-01 |
| Stage3-vs-Stage4 |
5.229200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.985790E-02 |
| Normal-vs-AfricanAmerican |
5.860000E-01 |
| Normal-vs-Asian |
2.806200E-01 |
| Caucasian-vs-AfricanAmerican |
7.360400E-02 |
| Caucasian-vs-Asian |
2.605600E-01 |
| AfricanAmerican-vs-Asian |
2.539800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.642500E-02 |
| Normal-vs-Female |
5.512100E-02 |
| Male-vs-Female |
5.831200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.720000E-02 |
| Normal-vs-Extreme_Weight |
5.070600E-01 |
| Normal-vs-Obese |
1.100630E-01 |
| Normal-vs-Extreme_Obese |
3.711800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.109600E-01 |
| Normal_Weight-vs-Obese |
8.564600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.091600E-01 |
| Extreme_Weight-vs-Obese |
2.722200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.336000E-01 |
| Obese-vs-Extreme_Obese |
8.095000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.639400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.983300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.022650E-01 |
| Normal-vs-Age(81-100Yrs) |
2.317800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.849500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.434400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.131400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.134800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.243000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.750110E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.599730E-02 |
| Normal-VS-Type2 PRCC |
7.767400E-01 |
| Normal-VS-KIRP CIMP |
2.2247999999947E-05 |
| Normal-VS-Unclassified PRCC |
2.327600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.550400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.80800049878849E-10 |
| Type1 PRCC-VS-Unclassified PRCC |
2.393200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.73100000000481E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
3.664000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.54400000019051E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.339000E-01 |
| Normal-vs-N1 |
1.445750E-01 |
| Normal-vs-N2 |
5.960800E-01 |
| N0-vs-N1 |
1.331220E-01 |
| N0-vs-N2 |
5.707200E-01 |
| N1-vs-N2 |
7.245000E-01 |
|
|
